People: Dr.Reddy's Laboratories Ltd (RDY.N)

RDY.N on New York Stock Exchange

37.44USD
11:30am EDT
Price Change (% chg)

$0.12 (+0.32%)
Prev Close
$37.32
Open
$37.34
Day's High
$37.56
Day's Low
$37.24
Volume
28,927
Avg. Vol
71,568
52-wk High
$38.74
52-wk Low
$27.28

Search Stocks

Summary

Name Age Since Current Position

G. Prasad

 52 2013 Executive Chairman of the Board, Chief Executive Officer

Satish Reddy

 45 2013 Executive Vice Chairman of the Board, Chief Operating Officer, Managing Director

Saumen Chakraborty

 51 2013 Chief Financial Officer, President, Global Head - Quality, HR and IT

R. Ananthanarayanan

 47 2010 President - Pharmaceutical Services and Active Ingredients

Abhijit Mukherjee

 54 2010 President - Global Generics

Amit Biswas

 52 2011 Executive Vice President - Integrated Product Development

Samiran Das

 52 2011 Executive Vice President - FTO and GGPM

Amit Patel

 37 2011 Executive Vice President - North America Generics

Umang Vohra

 41 2013 Executive Vice President, Head - North America

Raghav Chari

 42 Senior Vice President - Proprietary Products

M. Ramana

 44 2012 Senior Vice President - Emerging Markets, Global Generics

Cartikeya Reddy

 42 2004 Senior Vice President - Biologics

Sandeep Poddar

 2010 Compliance Officer, Company Secretary

Ravi Bhoothalingam

 65 2000 Non-Executive Independent Director

Bruce Carter

 2008 Non-Executive Independent Director

Ashok Ganguly

 76 2009 Non-Executive Independent Director

Omkar Goswami

 56 2000 Non-Executive Independent Director

Sridar Iyengar

 2011 Non-Executive Independent Director

J. Moreau

 63 2007 Non-Executive Independent Director

Kalpana Morparia

 63 2007 Non-Executive Independent Director

Anupam Puri

 2002 Non-Executive Independent Director

Milan Kalawadia

 IR Contact Officer

Kedar Upadhye

 IR Contact Officer
» Insider Trading

Biographies

Name Description

G. Prasad

 Mr. G. V. Prasad is Executive Chairman of the Board, Chief Executive Officer of Dr. Reddy’s Laboratories Limited. He has been appointed as Executive Chairman of the Board of the Company effective March 30, 2013. He joined the Board in 1986 and leads the core team that drives the growth and performance of Dr. Reddy’s. He has been Vice-Chairman & CEO of Dr. Reddy’s since 2001, when Cheminor Drugs Ltd, the company of which he was then Managing Director, merged with Dr. Reddy’s. Prasad has played a key role in the evolution of Dr. Reddy’s from a mid-sized pharmaceutical company into a globally respected pharmaceutical. He is widely credited as the architect of Dr. Reddy’s global generics strategy. He is dedicated to building the innovation side of the business and drives the Sustainability agenda at Dr. Reddy’s. He holds a degree in Chemical Engineering from the Illinois Institute of Technology, Chicago, USA and a Masters in Industrial Administration from Purdue University, USA.

Satish Reddy

 Mr. Satish Reddy is Executive Vice Chairman of the Board, Chief Operating Officer, Managing Director of Dr. Reddy’s Laboratories Limited. He has been appointed as Executive Vice Chairman of the Board of the Company effective March 30, 2013. He joined Dr. Reddy’s in 1993 as Executive Director. He played an instrumental role in the company’s transition from a bulk drugs manufacturer to a global player in the branded generics space by spearheading the Company’s entry into emerging markets. Satish steers Dr. Reddy’s Pharmaceutical Services and Active Ingredients (PSAI) and Global Generics businesses, two of the company’s core revenue generating streams. In 1997, he was appointed Managing Director.He graduated in Chemical Engineering from Osmania University, Hyderabad, and holds a Masters in Medicinal Chemistry from Purdue University, USA.

Saumen Chakraborty

 Mr. Saumen Chakraborty is Chief Financial Officer, President, Global Head - Quality, HR and IT of Dr. Reddy’s Laboratories Limited. He has been appointed as Chief Financial Officer of the company effective January 2, 2013. In this role, he is responsible for Company's Quality, Information Technology, Business Process Excellence, Human Resources, Corporate Communications and Supply Chain Effectiveness functions. Prior to this role, he was head of the Global Generics Operations along with Integrated Product Development across the organization. Mr. Chakraborty joined the Company in 2001 as Global Chief of Human Resources. He later took over as Chief Financial Officer in 2006 and then became Company's President — Corporate and Global Generics Operations in early 2009. He has 26 years of experience in strategic and operational aspects of management. Prior to joining the Company, he held various line manager, human resources and other positions, including Senior Manager (Finance and Accounts) in Eicher, and Vice President (Operations) in Tecumseh. A member of various industry forums, including the Confederation of Indian Industry and the National HRD Network, he graduated with honors as the valedictorian of his class from Visva-Bharati University in Physics, and went on to pursue management from the Indian Institute of Management, Ahmedabad. He continues to be responsible for Information Technology and Business Process Excellence.

R. Ananthanarayanan

 Dr. R. Ananthanarayanan is President - Pharmaceutical Services and Active Ingredients of Dr. Reddy’s Laboratories Limited. He holds B.Pharm., Ph.D. degree.

Abhijit Mukherjee

 Mr. Abhijit Mukherjee is President - Global Generics of Dr. Reddy’s Laboratories Limited. Before joining the Company, he worked with Atul Limited for 10 years, where he held numerous positions of increasing responsibility. In his last assignment there he was President, Bulk Chemicals and Intermediates Business, and Managing Director, Atul Products Limited. He started his career as a management trainee in Hindustan Lever Limited (“HLL”) and worked at that company for 13 years, including three years in a Unilever company. He was primarily involved in technical assignments in the aroma chemicals business in HLL and Unilever and also in detergents and sulphonation plants of HLL. He holds a degree in Chemical Engineering from the Indian Institute of Technology in Kharagpur, India.

Amit Biswas

 Dr. Amit Biswas is Executive Vice President - Integrated Product Development of Dr.Reddy's Laboratories Ltd. He holds Ph.D., Masters in Polymer Science and Bachelor of Technology in Chemical Engineering.

Samiran Das

 Mr. Samiran Das is Executive Vice President - Formulations Technical Operations (FTO) and Global Generics Portfolio Management (GGPM) of Dr.Reddy's Laboratories Ltd. He holds B.Tech in Mechanical Engineering.

Amit Patel

 Mr. Amit Patel is Executive Vice President - North America Generics of Dr. Reddy’s Laboratories Limited. He is responsible for executing company’s strategic efforts in the North American generics market. Prior to joining the Company in 2003, Amit was co-founder and Chief Executive Officer of a healthcare services startup called MedOnTime that was later acquired by CTIS Inc., at which he served as Vice President of Corporate Development. Earlier, he was a strategy consultant with Marakon Associates where he focused on value-based management and mergers and acquisition. He received a Bachelor of Science degree in Economics from the Wharton School of Business at the University of Pennsylvania, a Bachelor of Applied Science degree in Systems Engineering from the Moore School at the University of Pennsylvania, and a Master of Business Administration degree from Harvard Business School.

Umang Vohra

 Mr. Umang Vohra is Executive Vice President, Head - North America of Dr. Reddy’s Laboratories Limited. He resigned as Chief Financial Officer of the company effective January 2, 2013. He has over 14 years of experience across various functions within finance, strategic planning and corporate development. He is responsible for managing Company's organization’s global finance functions including among others Accounts and Controlling, Taxation, Compliance, Secretarial, Investor Relations and Treasury. He joined the Company in 2002, initially working as Deputy Chief Financial Officer, and has been part of several of Company's key initiatives like acquisitions, research and development, de-risking transactions, and operational improvements and migration to IFRS in Company's accounting, governance and finance processes. Prior to joining the Company, Mr. Vohra worked with Eicher and PepsiCo India. Mr. Vohra has a base degree in computer engineering and he holds an MBA with a specialization in Finance from TA Pai Institute of Management (TAPMI), India.

Raghav Chari

 Dr. Raghav Chari is Senior Vice President - Proprietary Products of Dr Reddys Laboratories Ltd. He heads Proprietary Products segment and is responsible for developing a viable portfolio of products across Company's New Chemical Entities and Differentiated Formulations businesses. Dr. Chari joined the Company in 2006 as Vice President- Corporate Development for Company's New Chemical Entities and Specialty business and has helped shape Company's Proprietary Products business strategy while developing alliance platforms. He started his career with McKinsey and Company, where he spent several years as an Associate, Engagement Manager and finally Associate Principal in McKinsey’s Pharmaceuticals and Medical Products practice. After McKinsey, he took leadership roles in strategy and business development with several smaller biotech companies. Prior to joining the Company, he was the head of the Corporate Strategy function at NPS Pharmaceuticals. Dr. Chari is a graduate in Mathematics and Physics from the California Institute of Technology and holds a Ph.D in Theoretical Physics from Princeton University.

M. Ramana

 Mr. M. V. Ramana is Senior Vice President & Head - Emerging Markets, Global Generics of Dr.Reddy's Laboratories Ltd. He holds MBA.

Cartikeya Reddy

 Dr. Cartikeya Reddy is Senior Vice President - Biologics of Dr. Reddy’s Laboratories Limited. He focuses on the development of biosimilar molecules for the Indian and global markets. Prior to joining in 2004, Mr. Reddy worked with Genentech Inc., where he was a Group Leader in the area of Cell Culture Process Development. Before that, he was with the Biotechnology Division of Bayer Corporation, where he led teams in the areas of Bioprocess Development and pilot scale manufacturing. Mr. Reddy holds a Master of Science degree and Ph.D. in Chemical Engineering from the University of Illinois, Urbana-Champaign, and was a Visiting Scholar at the Massachusetts Institute of Technology in Cambridge, Massachusetts, United States of America. He also graduated with a Bachelor of Technology degree in Chemical Engineering from the Indian Institute of Technology in Chennai, India.

Sandeep Poddar

 Mr. Sandeep Poddar is Compliance Officer, Company Secretary of Dr. Reddy's Laboratories Ltd.

Ravi Bhoothalingam

 Mr. Ravi Bhoothalingam is Non-Executive Independent Director of Dr. Reddy’s Laboratories Limited. He joined the Company’s Board in 2000. Mr. Bhoothalingam has served as the President of The Oberoi Group of Hotels and was responsible for the operations of the Group worldwide. He has also served as Head of Personnel at British American Tobacco (BAT) Plc, Managing Director of VST Industries Limited and as a Director of ITC Limited. He is also a Director of Sona Koyo Steering Systems Limited. Mr. Bhoothalingam holds a Bachelor of Science degree in Physics from St. Stephens College, Delhi and Master’s degree in Experimental Psychology from Gonville and Caius College, Cambridge University.

Bruce Carter

 Dr. Bruce L. A. Carter, Ph.D., is Non-Executive Independent Director of Dr. Reddy’s Laboratories Limited. Dr. Carter joined the Company’s Board in 2008. He was the Chairman of the Board and Chief Executive Officer of ZymoGenetics, Inc. USA. Dr. Carter was appointed Chairman of the Board of ZymoGenetics in April 2005. From April 1998 to January 2009, he served as Chief Executive Officer of ZymoGenetics. Dr. Carter first joined ZymoGenetics in 1986 as Vice President of Research and Development. In 1988 Novo Nordisk acquired ZymoGenetics and, in 1994, Dr. Carter was promoted to Corporate Executive Vice President and Chief Scientific Officer for Novo Nordisk A/S, the then parent company of ZymoGenetics. Dr. Carter led the negotiations that established ZymoGenetics as an independent company from Novo Nordisk in 2000. Dr. Carter held various positions of increasing responsibility at G D Searle & Co., Ltd. from 1982 to 1986 and was a Lecturer at Trinity College, University of Dublin from 1975 to 1982. Dr. Carter is the Executive Chairman of Immune Design Corp., USA, and is also on the Boards of: QLT Inc., Canada, TB Alliance, USA, and Xencor, USA. Dr. Carter received a B.Sc. with Honors in Botany from the University of Nottingham, England, and a Ph.D. in Microbiology from Queen Elizabeth College, University of London.

Ashok Ganguly

 Dr. Ashok Sekhar Ganguly is Non-Executive Independent Director of Dr. Reddys Laboratories Ltd. Dr. Ganguly was appointed as Director on the Board of the Company in 2009. He is currently the Chairman of ABP Private Limited (Ananda Bazar Patrika Group) and was a Director on the Central Board of Reserve Bank of India, from 2001 to 2009. He is a member of the Prime Minister’s Council on Trade and Industry as well as the Investment Commission and the India-USA CEO Council, set up by the Prime Minister of India and the President of the US. He is also a member of the National Knowledge Commission to the Prime Minister of India. He was the Chairman of Hindustan Lever Limited from 1980 to 1990, and member of the Unilever Board from 1990 to 1997 with responsibility for world-wide research and technology. He also serves as a non-Executive Director of Mahindra & Mahindra and Wipro Limited. He is a recipient of the ‘Padma Bhushan’ as well as ‘Padma Vibhushan, two of India’s prestigious civilian honours. At present, he serves as a member of the Rajya Sabha, the upper house of the Parliament of India.

Omkar Goswami

 Dr. Omkar Goswami, Ph.D., is Non-Executive Independent Director of Dr. Reddy’s Laboratories Limited. He joined the Company’s Board in 2000. Since April 2004, he has been the Founder and Chairman of CERG Advisory Private Limited, a consulting and advisory firm. He taught and researched Economics for 18 years at Oxford University, Delhi School of Economics, Harvard University, Tufts University, Jawaharlal Nehru University, Rutgers University and the Indian Statistical Institute, New Delhi. In March 1997, he moved away from formal academics to become the Editor of Business India, one of India’s prestigious business magazines. From August 1998 up to March 2004, Dr. Goswami served as the Chief Economist of the Confederation of Indian Industry the premier apex industry organization of India. He is also an Independent Director on the Boards of: Infosys Technologies Limited, Crompton Greaves Limited, IDFC Limited, Ambuja Cements Limited, Cairn India Limited, DSP Black Rock Investment Managers Private Limited, Godrej Consumer Products Limited, Max New York Life Insurance Company Limited, Max India Limited, and Avantha Power and Infrastructure Limited. A professional economist, Dr. Goswami did his Masters in Economics from the Delhi School of Economics and his D.Phil. (Ph.D.) from Oxford University.

Sridar Iyengar

 Mr. Sridar Iyengar is Non-Executive Independent Director of Dr. Reddy's Laboratories Ltd. He is an independent mentor investor in early stage start-ups and companies. For more than 35 years, he has worked in the U.K., U.S. and India with a number of companies, advising them on strategy and other issues. Mr. Iyengar is the former President of Foundation for Democratic Reforms in India, a U.S.-based non-profit organization. He is also an advisor to several venture and private equity funds in India. Earlier, Mr. Iyengar was a senior partner with KPMG in the U.S. and U.K. and served for three years as the Chairman and CEO of KPMG's operations in India. Mr. Iyengar holds a Bachelor of Commerce (Hons) degree from the University of Calcutta and is a Fellow of the Institute of Chartered Accountants in England and Wales.

J. Moreau

 Dr. J. P. Moreau is Non-Executive Independent Director of Dr. Reddy’s Laboratories Limited. He joined the Company’s Board in 2007. He founded Biomeasure Incorporated based near Boston and has been its President and CEO. Prior to that he was working as Executive Vice-President and Chief Scientific Officer of the IPSEN Group and was responsible for the Group’s Discovery and Innovation with facilities in Paris, London, Barcelona and Boston. He was Vice-President, Research from April 1994 and has been a member of the Executive Committee of IPSEN Group since that date. He has published over 50 articles in scientific journals and is named as an inventor of more than 30 patents. He is a regular speaker at scientific conferences and a member of Nitto Denko Scientific Advisory Board. Dr. Moreau was also responsible for establishing Kinerton Limited in Ireland in March 1989, a wholesale manufacturer of therapeutic peptides. Dr. Moreau is also on the Board of Phytomedics Inc. USA. Dr. Moreau has a degree in Chemistry from the University of Orleans and a D.Sc. in biochemistry. He has also conducted post-doctorate research at the École Polytechnique.

Kalpana Morparia

 Ms. Kalpana Morparia is Non-Executive Independent Director of Dr. Reddy’s Laboratories Limited. Ms. Morparia joined the Company’s Board in 2007. She is the Chief Executive Officer of J P Morgan, India, where she leads their Business Groups (investment banking, asset management, treasury services and principal investment management) & Service Groups (global research, finance, technology and operations). She is also a member of J P Morgan’s global strategy team headquartered in New York and the J P Morgan Asia Pacific Executive Committee. Prior to becoming CEO of J P Morgan India, Ms. Morparia served as Vice Chair on the Boards of ICICI Group. She joined the ICICI Group in 1975 and was the Joint Managing Director of ICICI Group from 2001 to 2007. She was named one of `The 50 Most Powerful Women’ in `International Business’ by Fortune magazine in 2008; one of the 25 most powerful women in Indian business by Business Today, a Indian business journal, in 2004, 2005, 2006 and 2008; and one of ‘The 100 most Powerful Women’ by Forbes magazine in 2006. She also serves on the Boards of: Bennett, Coleman & Co. Limited and CMC Limited. She is also a member of the Governing Board of Bharti Foundation. A graduate in law from Bombay University, Ms. Morparia has served on several committees constituted by the Government of India.

Anupam Puri

 Mr. Anupam P. Puri is Non-Executive Independent Director of Dr. Reddy’s Laboratories Limited. He joined the Company’s Board in 2002. From 1970 to 2000, Mr. Anupam Puri was with McKinsey & Company, a management consultancy firm. He worked globally with corporate clients in several industries on strategy and organizational issues, and also served several governments and multilateral institutions on public policy. Mr. Anupam Puri spearheaded the development of McKinsey’s India practice, oversaw the Asian and Latin American offices, and was an elected member of the Board. He is currently a management consultant. He is also on the Boards of: Mahindra & Mahindra Limited, Tech Mahindra Limited, Mumbai Mantra Media Limited and Dr. Reddy’s Laboratories Inc., USA. Mr. Anupam Puri holds a M. Phil. in Economics from Nuffield College, Oxford University, UK, an MA in Economics from Balliol College, Oxford University, and a BA in Economics from Delhi University, India.

Milan Kalawadia

Kedar Upadhye

Insider Trading

» Full list on Insider Trading
Search Stocks